Healthy Mom. Healthy Baby. Healthy World.
Personalized Nutritional Care in the Perinatal Time Period for Better Maternal & Fetal Health Outcomes Across the Lifespan.
What is GrowBaby® Health?
Since 2011, GrowBaby Health has implemented its Standard of Care PLUS Model, an evidence-informed pregnancy care approach designed to enhance traditional obstetric care. The model integrates nutrient biomarker assessment, genomic insights, and targeted supplements into routine prenatal care while embedding a nutrition professional within the clinical team. Through multiple delivery formats, including trimester-specific group education, individualized visits, and all virtual models, GrowBaby Health delivers care that is personalized, precise, and collaborative, bringing nutrition science, biomarker insight, and clinical care together to support healthier mothers and babies.
Integrated Nutrition-Driven Maternal Care is Here
-
We are a team of passionate medical professionals, nutritionists, thinkers, and doers committed to advancing maternal care with purpose and clarity. Collaboration and curiosity fuel our work. GrowBaby leads system solutions —bringing preventive nutrition, biomarker insights, and integrated care into the future of maternal health.
-
Our approach is simple, thoughtful, and human. Every collaboration begins with listening and leads to solutions we’re proud to deliver. Because healthcare is local, we tailor our work to the communities we serve—integrating nutrition, biomarker insights, and collaborative care along the way.
-
We partner with insurance companies, hospitals, health systems, universities, medical schools, government, and private organizations committed to improving maternal health. We work with people who care about doing things thoughtfully and doing them well. Meaningful change takes time, but it’s worth building together.
Our Applied Research Timeline
Major Study Announcement - Coming Soon!
2026
Needed Nutritional Care - Prospective Observational
2024-2026
Molina Healthcare - Prospective Observational
2022-2023
Stone Medical, PC - Retro/Prospective Observational
2010-2023
GrowBaby Outcomes Compared with U.S. National Averages
This visual compares GrowBaby outcomes versus the nation across key pregnancy indicators, illustrating how integrated nutritional care, personalized nutrigenomics, and biomarker-informed support can contribute to healthier pregnancies and better maternal and infant outcomes.
Results
Proven, decade-long outcomes with longitudinal impact.
-
Preterm birth (PTB) is defined as delivery before 37 completed weeks of gestation (Centers for Disease Control and Prevention [CDC], 2023; World Health Organization [WHO], 2023). Multiple biological and social factors contribute to PTB risk. Maternal obesity, exposure to psychosocial stressors such as adverse childhood experiences (ACEs) and post-traumatic stress disorder (PTSD), and chronic inflammation have all been associated with increased risk of preterm delivery (Liu et al., 2020; Blackmore et al., 2016; March of Dimes, 2022). A history of preterm birth is one of the strongest predictors of recurrence in subsequent pregnancies (ACOG, 2021). In the United States, preterm birth imposes a substantial economic burden, with annual societal costs estimated to exceed $26 billion, reflecting medical care, early intervention services, and long-term developmental support (Institute of Medicine, 2007; CDC, 2023). Preterm birth also disproportionately affects women of color and women insured through Medicaid, reflecting persistent disparities in maternal health and access to care in the United States (Martin et al., 2023; March of Dimes, 2023).
-
Gestational diabetes mellitus (GDM) is typically diagnosed using a two-step screening approach in the United States. An abnormal 50-g oral glucose challenge test (≥140 mg/dL) is followed by a diagnostic 100-g, 3-hour oral glucose tolerance test (OGTT), with GDM diagnosed when two or more glucose values exceed established thresholds, including the fasting value (ACOG, 2018; ADA, 2024). Maternal obesity and gestational diabetes both increase the likelihood of delivering a large-for-gestational-age (LGA) infant due to increased fetal exposure to glucose and insulin-mediated growth (HAPO Study Cooperative Research Group, 2008; Catalano & Shankar, 2017). Women diagnosed with GDM also face a substantially elevated long-term risk of developing type 2 diabetes mellitus, with approximately 35–60% progressing to diabetes within 10–20 years after pregnancy (Bellamy et al., 2009; CDC, 2022).
-
Pregnancy-induced hypertension (PIH), more commonly referred to as gestational hypertension, occurs when a previously normotensive woman develops new-onset hypertension after 20 weeks of pregnancy. It is defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg on two occasions at least four hours apart (American College of Obstetricians and Gynecologists [ACOG], 2020; American Heart Association, 2021). When hypertension occurs in combination with proteinuria or other signs of maternal organ dysfunction, the condition is classified as preeclampsia (ACOG, 2020).
Hypertensive disorders of pregnancy increase the likelihood of delivering small-for-gestational-age (SGA) infants due to placental vascular dysfunction and impaired fetal growth (Roberts & Hubel, 2009; Burton et al., 2019).
Women who experience hypertensive disorders during pregnancy also have an elevated long-term risk of developing chronic hypertension. Studies report that chronic hypertension develops within two to five years after pregnancy in approximately 50% of women with early-onset preeclampsia, 39% following gestational hypertension, and 25% following late-onset preeclampsia (Benschop et al., 2019; Brown et al., 2018).
-
American College of Obstetricians and Gynecologists. (2018). Gestational diabetes mellitus: ACOG Practice Bulletin No. 190. Obstetrics & Gynecology, 131(2), e49–e64.
American College of Obstetricians and Gynecologists. (2020). Gestational hypertension and preeclampsia: ACOG Practice Bulletin No. 222. Obstetrics & Gynecology, 135(6), e237–e260.
American College of Obstetricians and Gynecologists. (2021). Prediction and prevention of spontaneous preterm birth: ACOG Practice Bulletin No. 234. Obstetrics & Gynecology, 138(2), e65–e90.
American Diabetes Association. (2024). Management of diabetes in pregnancy: Standards of care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S282–S294.
American Heart Association. (2021). Hypertensive disorders of pregnancy and cardiovascular disease risk: A scientific statement from the American Heart Association. Hypertension, 77(2), e1–e19.
Bellamy, L., Casas, J. P., Hingorani, A. D., & Williams, D. (2009). Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. The Lancet, 373(9677), 1773–1779.
Benschop, L., et al. (2019). Cardiovascular risk after hypertensive disorders of pregnancy. Hypertension, 73(1), 171–178.
Blackmore, E. R., et al. (2016). Previous prenatal loss as a predictor of perinatal depression and PTSD. Journal of Women's Health, 25(7), 712–718.
Brown, M. C., et al. (2018). Hypertensive disorders of pregnancy and future cardiovascular disease risk.Hypertension, 72(2), 241–247.
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019). Pre-eclampsia: Pathophysiology and clinical implications. Physiological Reviews, 99(1), 541–597.
Catalano, P. M., & Shankar, K. (2017). Obesity and pregnancy: Mechanisms of short- and long-term adverse consequences for mother and child. BMJ, 356, j1.
Centers for Disease Control and Prevention. (2023). Preterm birth. U.S. Department of Health and Human Services.
Centers for Disease Control and Prevention. (2022). Gestational diabetes and risk of type 2 diabetes. U.S. Department of Health and Human Services.
HAPO Study Cooperative Research Group. (2008). Hyperglycemia and adverse pregnancy outcomes. New England Journal of Medicine, 358(19), 1991–2002.
Institute of Medicine. (2007). Preterm birth: Causes, consequences, and prevention. National Academies Press.
Liu, B., et al. (2020). Maternal obesity and risk of preterm birth: A systematic review and meta-analysis. Obesity Reviews, 21(2), e12939.
March of Dimes. (2023). 2023 Report Card for the United States: Preterm birth and disparities.
Martin, J. A., Hamilton, B. E., & Osterman, M. J. K. (2023). Births: Final data for 2022. National Vital Statistics Reports, 72(1).
Roberts, J. M., & Hubel, C. A. (2009). The two-stage model of preeclampsia. The Lancet, 373(9677), 1811–1812.
World Health Organization. (2023). Preterm birth.
Changing the Care We Give
"Maternal health in the United States calls for a more coordinated approach. GrowBaby has spent the last decade building and testing a model that integrates nutrition science, biomarker insights, select nutrigenomics, targeted supplement solutions, and team-based care. We are ready to partner with organizations that want to bring preventative, evidence-informed care into the future of maternal health."
— Emily Stone Rydbom, MDHc, BCHN, CNP, Co-Founder & CEO, GrowBaby Health
